Skip to main content

Theleme Partners LLP

Location
London, X0
Portfolio Value
Mid $1,501,107,417
Diversification
Moderately concentrated
Filing Date
Global Rank
#1,167 / 8,232 ▲ 81
Top Industry
Biotechnology 27.2%
3Y Alpha vs SPY
-29.2%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
-23.1%
SPY
+76.3%
Annualised alpha
-29.2%
Max drawdown
−53.9%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

9 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
27.2%
+8.7 pts
Top 5
80.6%
+9.5 pts
Top 10
100.0%
0.0 pts
HHI
1,603
Jun 2023 → Mar 2026 · range 1,120 – 3,205
Moderately concentrated+294

Portfolio Trend

25 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 27.2% $408,850,845
Communication Services 18.3% $274,427,894
Consumer Cyclical 16.8% $251,770,225
Financial Services 16.0% $239,653,565
Technology 15.3% $228,971,172
Industrials 6.5% $97,433,716

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
6 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
1 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
1 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
9 positions · $1,501,107,417 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History